Laurus Labs Q3 Results: Stock gains after earnings beat, 20%-plus margins

Shares of Laurus Labs Ltd. gained up to 2.5% on Friday, January 23, in response to the company's quarterly results for the October-December period, which were better than expectations across parameters.

Revenue for the quarter stood at ₹1,778.3 crore, a growth of 25.7% from last year's figure of ₹1,415 crore. The figure is also higher than the CNBC-TV18 poll figure of ₹1,610.4 crore. The company saw strong momentum during the quarter led by the CDMO division.

Earnings Before Interest, Tax, Depreciation and Amortisations (EBITDA) for the quarter grew by 68% from the year-ago quarter to ₹481 crore from ₹286 crore earlier. A CNBC-TV18 poll had projected the figure to be ₹366 crore.

EBITDA margin expanded by over 700 basis points to 27% from 20.2% last year. This is the fifth straight quarter of Laurus Labs reporting an EBITDA margin figure of more than 20%. Margins were also higher than the CNBC-TV18 poll of 22.7%. The margin performance was also aided by operating leverage.

In its investor presentation, Laurus Labs said that they are well on track to deliver healthy operational growth for financial year 2026.

Shares of Laurus Labs have surged to the highs of the day, currently trading 3.5% higher at ₹1,040. The stock is up 78% in the last 12 months.